This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GSI Technology Reports Developments Related To Pending Patent Litigation With Cypress Semiconductor

GSI Technology, Inc. (Nasdaq: GSIT) today responded to Cypress Semiconductor Corp.’s January 18, 2012 press release regarding the status of pending patent litigation between the two companies.

Lee-Lean Shu, GSI’s President and CEO, noted, “In its most recent press release, Cypress has once again chosen to make misleading statements in the press rather than fight the lawsuit on the merits before the International Trade Commission (ITC). Their press release states: 'Cypress expands its patent infringement complaint.' In truth," said Shu, "contrary to Cypress’ report, the judge in the ITC proceeding specifically denied Cypress’ request to expand its complaint – Order No. 20: Denying Complainant Cypress Semiconductor Corp.’s Motion for Leave to Amend the Complaint (dated January 4, 2012). Further, the only recent order allowing the expansion of the pleadings in the proceeding was an order allowing GSI to amend its responsive pleading – Order No. 22: Granting Respondents’ Motion for Leave to Amend Their Responses to the Second Amended Complaint and Notice of Investigation (dated January 9, 2012).

“The facts are that GSI has had a remarkable series of victories during the pre-trial phase of the ITC proceeding,” continued Shu. "In another recent order, for example, the judge also denied a motion by Cypress that would have expanded the scope of Cypress’ discovery. In addition, the U.S. Patent and Trademark Office (PTO) has issued initial office actions rejecting a number of claims of the Cypress patents as invalid on the basis of prior art, as GSI announced in November."

“It continues to be Cypress’ strategy to attempt to intimidate customers and prospective purchasers of GSI’s technologically superior products by making misleading statements about developments in the patent litigation,” said Didier Lasserre, GSI’s Vice President of Worldwide Sales. “As the March 2012 trial date approaches, Cypress seems to be ratcheting up these efforts,” he added.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs